← Eichor
Study identifier: NCT07670975 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)

Condition: Crohn Disease Colitis · Colitis, Ulcerative · Inflammatory Bowel Diseases  ·  Sponsor: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

PhaseN/A
Planned participants50
Who can joinAll sexes, 6 Years to 17 Years
Healthy volunteersNo

About this study

This multicenter prospective observational non-pharmacological study aims to evaluate resting energy expenditure (REE) in pediatric patients affected by inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. REE will be measured using indirect calorimetry and estimated using predictive equations. The study also aims to investigate the relationship between REE, disease activity, and dietary or pharmacological treatments. Clinical, laboratory, anthropometric, nutritional, and disease activity data will be collected during routine clinical follow-up at diagnosis, after induction therapy, and during follow-up visits.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Trial Center (CTC)  ·  0131206893  ·  clinicaltrialcenter@ospedale.al.it

Always discuss trial participation with your own doctor first.

Locations (1)

Pediatric UnitAlessandria, Piedmont, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07670975